| Financial Year |
March 31 2023 |
| Monetary Funds |
645,982,521.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
114,711,750.91 |
| Advances to Suppliers |
86,899,415.99 |
| Other Receivables |
25,322,183.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
836,009,558.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,384,105.91 |
| Total Current Assets |
1,731,309,536.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,530,463.43 |
| Investment Properties |
-- |
| Fixed Assetes |
3,032,405,968.81 |
| Under-construction Projects |
866,397,039.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
72,032,793.01 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
233,600,783.44 |
| R&D expenses |
-- |
| Goodwill |
27,261,936.94 |
| Long-Term Deferred and Prepaid Expenses |
46,437,492.01 |
| Deferred Income Tax Assets |
12,621,469.53 |
| Other Non-Current Assets |
92,169,511.08 |
| Sub-Total of Non-Current Assets |
4,648,559,407.32 |
| Total Assets |
6,379,868,943.72 |
| Short-Term Loans |
1,117,816,085.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
337,058,304.20 |
| Accounts Payable |
171,106,883.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,984,986.53 |
| Taxes Payable |
28,415,685.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
172,045,716.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
121,822,381.91 |
| Other Current Liabilities |
31,581,673.00 |
| Sub-Total of Current Liabilities |
2,154,995,807.36 |
| Long-term Loans |
804,646,503.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,279,843.30 |
| Deferred Income Tax Liabilities |
14,746,256.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,017,051,223.86 |
| Total Liabilities |
3,172,047,031.22 |
| Paid-In Capital(Or Share Stock) |
337,998,561.00 |
| Capital Surplus |
1,171,483,955.90 |
| Surplus Reserve |
152,562,351.14 |
| LESS:Treasury Stock |
177,799,733.19 |
| Undistributed Profits |
1,215,116,062.92 |
| Minority Stockholder's Interest |
520,481,192.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,687,340,720.15 |
| Owner's Equity（Stockholder's Equity） |
3,207,821,912.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,379,868,943.72 |
